Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parkinson's disease: A review
Vinay Goyal, Divya M. Radhakrishnan
Neurology India (2018) Vol. 66, Iss. 7, pp. 26-26
Closed Access | Times Cited: 208

Showing 1-25 of 208 citing articles:

Flavonoids: Their putative neurologic roles, epigenetic changes, and gut microbiota alterations in Parkinson’s disease
Yasemin Açar, Duygu Ağagündüz, Paola De Cicco, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115788-115788
Open Access | Times Cited: 77
Curcumin-Based Nanomedicines in the Treatment of Inflammatory and Immunomodulated Diseases: An Evidence-Based Comprehensive Review
Lucas Fornari Laurindo, Gabriel Magno de Carvalho, Bárbara de Oliveira Zanuso, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 229-229
Open Access | Times Cited: 52
Automatic and non-invasive Parkinson’s disease diagnosis and severity rating using LSTM network
E Balaji, D. Brindha, Vinodh Kumar Elumalai, et al.
Applied Soft Computing (2021) Vol. 108, pp. 107463-107463
Closed Access | Times Cited: 90
Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review
Tapan Behl, Gagandeep Kaur, Ovidiu Frăţilă, et al.
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 66
Rotenone induces regionally distinct α-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice
Savannah M. Rocha, Collin M. Bantle, Tawfik Aboellail, et al.
Neurobiology of Disease (2022) Vol. 167, pp. 105685-105685
Open Access | Times Cited: 46
Aluminium in the Human Brain: Routes of Penetration, Toxicity, and Resulting Complications
Łukasz Bryliński, Katarzyna Kostelecka, Filip Woliński, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7228-7228
Open Access | Times Cited: 40
Mass Spectrometry–Based Proteomics Analysis of Human Substantia Nigra From Parkinson's Disease Patients Identifies Multiple Pathways Potentially Involved in the Disease
Yura Jang, Olga Pletniková, Juan C. Troncoso, et al.
Molecular & Cellular Proteomics (2022) Vol. 22, Iss. 1, pp. 100452-100452
Open Access | Times Cited: 39
The benefits of hesperidin in central nervous system disorders, based on the neuroprotective effect
Xinyu Li, Wei Huang, Rongrong Tan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114222-114222
Open Access | Times Cited: 34
The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson’s Disease: A Promising Therapeutic Approach
Y. So, Jae-Ung Lee, Ga-Seung Yang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1071-1071
Open Access | Times Cited: 10
Oxidative stress and dysregulated long noncoding RNAs in the pathogenesis of Parkinson’s disease
Jialu Wang, Meitong Liu, Jiuhan Zhao, et al.
Biological Research (2025) Vol. 58, Iss. 1
Open Access | Times Cited: 1
Neuroprotective effect of biosynthesised gold nanoparticles synthesised from root extract of Paeonia moutan against Parkinson disease – In vitro & In vivo model
Jinwei Xue, Tongtong Liu, Yongdan Liu, et al.
Journal of Photochemistry and Photobiology B Biology (2019) Vol. 200, pp. 111635-111635
Closed Access | Times Cited: 56
Chemically induced models of Parkinson's disease
Thilaga Thirugnanam, Kirankumar Santhakumar
Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology (2021) Vol. 252, pp. 109213-109213
Closed Access | Times Cited: 48
Role of SUMOylation in Neurodegenerative Diseases
Nicolas Mandel, Nitin Agarwal
Cells (2022) Vol. 11, Iss. 21, pp. 3395-3395
Open Access | Times Cited: 30
Neurological Insights into Sleep Disorders in Parkinson’s Disease
Subramanian Thangaleela, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, et al.
Brain Sciences (2023) Vol. 13, Iss. 8, pp. 1202-1202
Open Access | Times Cited: 22
The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders
Anna Stasiłowicz-Krzemień, Wiktoria Nogalska, Zofia Maszewska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5749-5749
Open Access | Times Cited: 6
Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson’s Disease
Gagandeep Kaur, Tapan Behl, Simona Bungău, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 2, pp. 233-247
Open Access | Times Cited: 46
Emerging role of S100B protein implication in Parkinson’s disease pathogenesis
Efthalia Angelopoulou, Yam Nath Paudel, Christina Piperi
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 4, pp. 1445-1453
Closed Access | Times Cited: 40
The Positive Role and Mechanism of Herbal Medicine in Parkinson’s Disease
Rong Yin, Jie Xue, Yanfeng Tan, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 40
Neuroprotective effects of oleuropein: Recent developments and contemporary research
Masood Sadiq Butt, Urwa Tariq, Iahtisham Ul-Haq, et al.
Journal of Food Biochemistry (2021) Vol. 45, Iss. 12
Open Access | Times Cited: 39
Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases
Claudia Riccardi, Filomena Napolitano, Daniela Montesarchio, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1897-1897
Open Access | Times Cited: 35
Astragaloside IV Protects 6-Hydroxydopamine-Induced SH-SY5Y Cell Model of Parkinson’s Disease via Activating the JAK2/STAT3 Pathway
Zhenghu Xu, Dongfeng Yang, Xiaojing Huang, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 33
Parkinson’s disease diagnosis using neural networks: Survey and comprehensive evaluation
M. Tanveer, Ashraf Haroon Rashid, Rahul Kumar, et al.
Information Processing & Management (2022) Vol. 59, Iss. 3, pp. 102909-102909
Closed Access | Times Cited: 26
Blood-brain Barrier and Neurovascular Unit Dysfunction in Parkinson's Disease: From Clinical Insights to Pathogenic Mechanisms and Novel Therapeutic Approaches
Sarah Lei Qi Khor, Khuen Yen Ng, Rhun Yian Koh, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 3, pp. 315-330
Closed Access | Times Cited: 15
Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinson’s disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin
Chenhong Guo, Ting Cao, Long Tai Zheng, et al.
Acta Pharmacologica Sinica (2020) Vol. 41, Iss. 4, pp. 499-507
Open Access | Times Cited: 33
Recent Progress in Non-motor Features of Parkinson’s Disease with a Focus on Circadian Rhythm Dysregulation
Yufei Liu, Long Niu, Xinyao Liu, et al.
Neuroscience Bulletin (2021) Vol. 37, Iss. 7, pp. 1010-1024
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top